Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-21

Clinical Trial Update: Comparison of Type 2 Diabetes Pharmacotherapy Regimens

View source ↗

Summary

A Kaiser Permanente-sponsored trial comparing pharmacotherapy regimens for type 2 diabetes has completed, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Kaiser Permanente | Conditions: Type 2 Diabetes Mellitus, Cardiovascular Diseases | Status: COMPLETED | Results posted: 2025-11-21